Steadman Philippon Research Institute

Organization Overview

Steadman Philippon Research Institute is located in Vail, CO. The organization was established in 1989. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Steadman Philippon Research Institute employed 77 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Steadman Philippon Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Steadman Philippon Research Institute generated $15.2m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 2.4% each year. All expenses for the organization totaled $14.2m during the year ending 12/2021. While expenses have increased by 7.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

DEDICATION TO KEEPING PEOPLE PHYSICALLY ACTIVE THROUGH ORTHOPAEDIC RESEARCH AND EDUCATION.

Describe the Organization's Program Activity:

Part 3 - Line 4a

CENTER FOR REGENERATIVE AND PERSONALIZED MEDICINE (CRPM) - THE PRIMARY FOCUS OF THE CENTER FOR REGENERATIVE AND PERSONALIZED MEDICINE (CRPM) AT THE STEADMAN PHILIPPON RESEARCH INSTITUTE IS TO IDENTIFY, CHARACTERIZE, AND CLINICALLY TRANSLATE THE USE OF ADULT STEM CELLS IN THE TREATMENT OF A VARIETY OF MUSCULOSKELETAL TISSUES AFTER INJURIES, DISEASE AND AGING. THE CRSM IS COMPRISED OF AN INTERNATIONALLY DIVERSE GROUP OF INVESTIGATORS THAT APPLY A LARGE BATTERY OF TECHNIQUES TO ISOLATE, CHARACTERIZE, AND CLINICALLY MODEL THE USE OF MUSCLE-DERIVED CELLS (MDCS).


BIOMEDICAL ENGINEERING (BME) IS A MULTIDISCIPLINARY LABORATORY WHICH APPLIES QUANTITATIVE, ANALYTICAL, AND INTEGRATIVE METHODS TO THE FIELD OF ORTHOPAEDIC MEDICINE. THE MULTITALENTED RESEARCH STAFF INTEGRATES CLINICAL CARE, RESEARCH, AND EDUCATION WITH THE RESOURCES OF WORLD-RENOWNED MEDICAL DOCTORS IN ORDER TO IMPROVE THE TREATMENT OF MUSCULOSKELETAL DISEASES. THIS FOCUSED APPROACH IS DESIGNED TO MAINTAIN AND ENHANCE ATHLETIC PERFORMANCE, HEALTH, AND QUALITY OF LIFE FOR THE PROFESSIONAL, SEMI-PROFESSIONAL, COLLEGIATE, HIGH SCHOOL AND THE RECREATIONALLY ACTIVE INDIVIDUAL THROUGH AN EMPHASIS ON BENCH-TO-BEDSIDE RESEARCH. SEE CONTINUATION ON SCHEDULE O. THE PROGRAMS PROVIDED BY THE DEPARTMENT OF BIOMEDICAL ENGINEERING ARE UNIQUE AND DIVERSE AND THEY ENCOMPASS A COMPLETE RANGE OF SERVICES FOR THE PHYSICALLY ACTIVE OR THOSE WISHING TO RETURN TO AN ACTIVE LIFESTYLE AFTER INJURY.


CENTER FOR OUTCOMES-BASED ORTHOPAEDIC RESEARCH (COOR) HAS BEEN DEFINED AS THE STUDY OF THE END RESULTS OF MEDICAL TREATMENT, WHICH IS INTENDED TO PROVIDE SCIENTIFIC EVIDENCE TO SUPPORT PATIENT AND PHYSICIAN DECISIONS REGARDING MEDICAL TREATMENT. THE INSTITUTES OUTCOMES RESEARCH IS BASED ON PHYSICIAN/PATIENT ASSESSMENT OF IMPROVEMENT IN FUNCTION, QUALITY OF LIFE AND PATIENT SATISFACTION. OUTCOMES RESEARCH PROVIDES A TOOL TO LINK THE PATIENT'S PERSPECTIVE TO THE EFFECTIVENESS OF HEALTH TREATMENT. THIS ALLOWS FOR INCREASED PARTICIPATION BY PATIENTS IN THE DECISION-MAKING PROCESS REGARDING THE KIND OF CARE THEY DESIRE. OUR GOAL IN COOR IS TO LEARN FROM PATIENTS AND VALIDATE TREATMENT PROTOCOLS IN AN EFFORT TO IMPROVE THE QUALITY OF HEALTH CARE FOR EVERY PATIENT.


SURGICAL SKILLS LABORATORY; EDUCATION AND FELLOWSHIP PROGRAM; DEPARTMENT OF TECHNOLOGY AND MULTIMEDIA COMMUNICATIONS, AND IMAGING RESEARCH


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Johnny Huard Phd
Chief Scientific Officer; Director, Crsm
$450,000
Scott Tashman Phd
Director, Biomedical Engineering
$125,000
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$263,750
Related organizations$0
Government grants $4,903,235
All other contributions, gifts, grants, and similar amounts not included above$9,876,967
Noncash contributions included in lines 1a–1f $861,359
Total Revenue from Contributions, Gifts, Grants & Similar$15,043,952
Total Program Service Revenue$122,584
Investment income $0
Tax Exempt Bond Proceeds $0
Royalties $39,857
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events -$29,506
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $15,214,073

Grants Recieved

Over the last fiscal year, we have identified 2 grants that Steadman Philippon Research Institute has recieved totaling $10,200.

Awarding OrganizationAmount
Welsh Family Foundation Inc

Vero Beach, FL

PURPOSE: UNRESTRICTED

$10,000
Currie Family Foundation

Timnath, CO

PURPOSE: GENERAL OPERATIONS

$200
View Grant Recipient Profile

Endowment Analysis

Beg. Balance$2,287,268
Earnings$254,327
Net Contributions$1,000,000
Other Expense$72,095
Ending Balance$3,469,500

Create an account to unlock the data you need.

or